In specialist B2B pharmacy, the risk sits with the pharmacy. The decisions, often, sit with the partner.
A clinic chooses the therapy area to enter, the patient group to serve, the commercial model to run. The pharmacy is regulated, audited, and held accountable for the patient outcomes that flow from those choices — even where the choices themselves are not ours to make.
That asymmetry is structural. It is not a bug in B2B pharmacy. It is the form of the relationship.
We work with partners who lead with patient experience, brand, and commercial design. Many are scaling into therapy areas they are entering for the first time. Some are not regulated entities themselves. That isn’t a criticism — it’s why partners choose specialist pharmacy infrastructure rather than running it themselves.
But the tension between commercial momentum and clinical conservatism is real. Unaddressed, it is exactly where industry harms originate. Addressed honestly, it’s what makes scalable specialist services safe.
Pharmacy is heavily regulated, and rightly so. But regulation describes the floor — the conditions under which a pharmacy is permitted to operate. It does not describe what good looks like at scale, in a particular therapy area, working with a particular kind of partner. Closing the gap between compliant and genuinely safe at scale is work the regulator cannot do for the industry. It has to be done by the operators within it.
We took on that work because, as the regulated entity, we would carry the consequences if it weren’t done.
Weight management is where Onescript started, and where this argument is sharpest. It is one of the most heavily scrutinised therapy areas in UK pharmacy today. Regulator guidance has repeatedly arrived after the harms it addresses — naming risks the industry had already encountered.
We chose to engineer for that scrutiny from day one. Multi-signal order screening, supply-chain provenance, automated safeguards, and ongoing dispensing intelligence are part of how we operate today — not because the regulator required them when we were establishing the service, but because we expected the regulator to arrive at them eventually, and decided we’d rather be ahead than catching up.
The model has held up. As scrutiny has tightened, our floor has not had to move.
The 1° Standard is the form that thinking takes when applied to partnership.
It is a tiered framework that qualifies clinics to operate through Onescript, maintains assurance over the life of the partnership, and gives partners a visible way to signal they operate to it. Three tiers progress from entry-level qualification through substantiated assurance to embedded operational alignment. Every live partner holds the entry tier; partners earn the higher tiers over time as the relationship deepens and evidence accumulates.
We won’t walk through the full architecture here — that’s a separate piece. The point worth making is what it isn’t: it isn’t a replacement for regulation, a competitor to LegitScript, or a commercial badge. It’s an internal standard we apply to ourselves and to the partners who operate through us — shaped to close the gap between the regulatory floor and the practical safety bar that scaled specialist services need to hold.
The 1° Standard isn’t something we wrote for ourselves and the regulators alone. We wrote it for the partnership — which means for the patients those partnerships serve, and for the partners we serve them with.
In practice, partners we’ve worked with have come to value the Standard not as something they had to clear, but as something that strengthened the service they were running. Clinically, because operating to a higher safety bar reduces risk in places it’s hard to see from the commercial side of the table. Commercially, because patients, regulators, insurers, and pharma partners increasingly look for assurance that goes beyond the regulatory floor — and a partner that can demonstrate it has a stronger service to sell.
A standard isn’t us telling partners what to do. It’s us saying this is how we think it gets done well — let’s work out together what better looks like for your service. That’s the conversation we’d rather be in.
We don’t claim the 1° Standard is the answer to the gap. We think it’s our answer. The floor will keep being raised — by regulators, by good operators, by harms that should never happen and lessons we’d all rather not have to learn — and any standard worth writing should expect to evolve with it.
This is the first piece. There will be more. We’d rather operate in an industry where the question of what good looks like at scale gets asked publicly, often, and by people willing to commit to an answer.